Starling Oncology lifts FY 2026 revenue outlook to $650-$670 millionPUBT·Aug 6 at 04:50 PMSTLN-1.15%TOI0.00%
Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOIPUBT·Aug 3 at 07:06 AMTOI0.00%STLN-1.15%
Major Investor Quietly Boosts Position in Oncology PowerhouseTip Ranks·Jul 22 at 09:02 PMTOI0.00%STLN-1.15%
Oncology Institute 10% owner Jorey Chernett buys 18,000 shares valued at $94,860PUBT·Jul 22 at 08:56 AMTOI0.00%STLN-1.15%
Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95PUBT·Jul 16 at 07:06 PMTOI0.00%STLN-1.15%
Biotech Stocks Hit 52-Week Highs - TOI, IKT, ANRO, ELV, PRVArttnews·Jul 15 at 02:55 AMANRO+0.09%IKT+1.70%
Oncology Institute (NASDAQ:TOI) Sets New 1-Year High Following Insider Buying ActivityMarket Beat·Jul 14 at 12:20 AMTOI0.00%STLN-1.15%
Oncology Institute 10% owner Jorey Chernett acquires 15,000 common shares worth $87,750PUBT·Jul 13 at 10:34 AMTOI0.00%STLN-1.15%
Oncology Institute repays USD 86 million Deerfield convertible note via OrbiMed refinancingPUBT·Jul 7 at 04:00 PMTOI0.00%STLN-1.15%
The Oncology Institute, Inc. (NASDAQ:TOI) Receives Average Recommendation of "Moderate Buy" from BrokeragesMarket Beat·Jul 6 at 09:14 AMTOI0.00%STLN-1.15%
Oncology Institute 10% owner Jorey Chernett buys $90,360 of common sharesPUBT·Jun 24 at 08:32 AMTOI0.00%STLN-1.15%
